(±)-SLV319

CAS No.	362519-49-1	Cat. No.	BCP30069
Name	(±)-SLV319
Synonyms	(±)-BMS-646256; (±)-BMS646256; (±)-BMS 646256; (±)-SLV-319; (±)-SLV 319; SLV319; (±)-JD-5001; (±)-JD 5001; (±)-JD5001; (±)-Ibipinabant;
Formula	C23H20Cl2N4O2S	M. Wt	487.40

Description	(±)-SLV319 is the racemate of SLV319. SLV319 is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM.Ibipinabant, also known as BMS-646256, JD-5001 and SLV-319, is a potent and highly selective CB1 antagonist. It has potent anorectic effects in animals, and was researched for the treatment of obesity, although CB1 antagonists as a class have now fallen out of favour as potential anorectics following the problems seen with rimonabant, and so ibipinabant is now only used for laboratory research, especially structure-activity relationship studies into novel CB1 antagonists.
Pathways	GPCR/G Protein
Targets	Cannabinoid Receptor

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.